← CompaniesClaim Company
CeloNova BioSciences
Top Insights
  • Contribute something unique about CeloNova BioSciences that may be helpful for others (ex. interview tips, choosing teams, unique culture, etc).

  • About

    Introducing the world's first and only non drug-eluting, nanocoated coronary stent that allows physicians to treat patients with short, 1-month DAPT.

    http://www.celonova.com
    Website
    2000
    Year Founded
    90
    # of Employees
    $10M-$50M
    Estimated Revenue
    Headquarters

    Get Verified Salaries in your Inbox

    Subscribe to verified offers. You’ll get the breakdown of compensation details by email. Learn More →

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.